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Simple snoring (SS), in the absence of obstructive sleep apnoea (OSA) is a common problem, 
yet our understanding of its causes and consequences is incomplete. Our understanding is 
blurred by the lack of consistency in the definition of snoring, methods of assessment, and 
degree of concomitant complaints. Further, it remains contentious whether SS is 
independently associated with daytime sleepiness, or adverse health outcomes including 
cardiovascular disease and metabolic syndrome. Regardless of this lack of clarity, it is likely 
that SS exists on one end of a continuum, with OSA at its polar end. This possibility 
highlights the necessity of considering an otherwise ‘annoying’ complaint, as a serious risk 
factor for the development and progression of sleep apnoea, and consequent poor health 
outcomes. In this review, we: 1) highlight variation in prevalence estimates of snoring; 2) 
review the literature surrounding the distinctions between SS, upper airway resistance 
syndrome (UARS) and OSA; 3) present the risk factors for SS, in as far as it is distinguishable 
from UARS and OSA; and 4) describe common correlates of snoring, including cardiovascular 
disease, metabolic syndrome, and daytime sleepiness. 
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Snoring is a common problem, yet prevalence estimates vary widely. The lack of clarity 
around snoring prevalence is in part a reflection of unresolved issues concerning its 
definition(s). Most authors agree on what snoring is:  “…a fluttering sound created by the 
vibrations of pharyngeal tissues…” (1); or more generally “…a sound produced by the upper 
aerodigestive tract during sleep…” (2). There is less agreement as to what counts as clinically 
significant snoring, as well as the nature of the distinctions, qualitative or quantitative, 
between simple snoring (SS), upper airway resistance syndrome (UARS) and obstructive 
sleep apnoea (OSA). This picture is further confused by the variety of actual and proposed 
assessment methods for each of these disorders, and the variety of putative physiological 
and anatomical correlates within each snoring classification. Finally, the degree of 
associated daytime dysfunction is often, but not consistently, used as a distinguishing 
diagnostic marker and this in turn has (confusing) implications for clinicians and treatment 
decisions.  
Prevalence 
In one of the largest prevalence studies to date, a Hungarian population survey of 12,643 
people, 50% self-reported being loud snorers (3). The sample was subdivided into loud and 
habitual snorers, and further by gender. Thirty-seven percent of males self-identified as 
being loud snorers with breathing pauses and 23% habitual snorers; whereas in females 21% 
identified as loud snorers with breathing pauses and 21% as habitual snorers. Several 
factors may influence prevalence variation across studies, and between nations, including 
socio-demographic characteristics of study populations; health behaviours and variation in 
assessment methods and classification categories. For these reasons, the authors, like other 
researchers, concluded that cross-nation comparisons are not possible. Prior prevalence 
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estimates in other epidemiological studies varied between 2% and 85%, depending on 
measurements and population variables (4). A similar large population based study of 4533 
Latin Americans, reported a prevalence of ~60% in four Latin American cities, with 
approximately 10% higher prevalence in males than females (4). There have been other 
recent international prevalence estimates. Adewole and colleagues estimate a 32% habitual 
snoring prevalence in a small sample of 370 adults in Nigeria (5). In one of the first studies in 
a Pakistani population, Hussain and colleagues surveyed 2497 adults and reported an 
average prevalence of self-reported snoring of 32%, yet in middle age (>35 years of age) 
prevalence was 46% (6). In a sample of 8583 Japanese adults (35-79 years of age) 
prevalence rates were 24% for men and 10% for women (7). This sex difference is perhaps 
not surprising given that being male is one of the risk factors for snoring (see section below). 
As well as there being prevalence variation between studies, there is also variation within 
studies which have looked at the ethnic mix of their populations. Among 1611 Malaysian 
adults with an overall habitual snoring prevalence of 47%, Indian and Chinese individuals 
were significantly more likely to report snoring than Malays (8). Further, in a survey of 2298 
adults of Indian, Chinese and Malaysian origin, for Indian individuals the odds of reporting 
snoring were 1.5 times greater than in Chinese individuals (9). European estimates tend to 
be around 20-40% (1). Possible reasons for ethnic differences in snoring will be considered 
when we discuss risk factors below. 
 
A major limitation of these studies is the definition of habitual snoring. Hussain and 
colleagues distinguished between habitual and occasional snoring (5.4% versus 26.9%) with 
the former being defined as “daily” (6). Other studies have defined habitual snoring as 
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"often"; or more than 3, 4 or 5 times per week. This is highlighted in one of the few meta-
analyses in the epidemiology of snoring (10). This systemic review and meta-analysis of 63 
studies reporting on gender differences in the prevalence of snoring identified significant 
methodological heterogeneity in population, age, sampling frames and assessment 
methods. Furthermore they found that ~62% of studies did not specify definitional criteria, 
and 81% did not ask about the loudness of snoring. As such estimates of snoring are 
somewhat piecemeal, and with continuing lack of internationally agreed definitions, 
classifications and measurement tools, are likely to remain so.   
A continuum of snoring? 
Most authors support a continuum of snoring from SS through UARS up to and through 
degrees of OSA (for example, see 11, 12). OSA has the clearest definition and diagnostic 
criteria. Objectively it is marked by partial or complete collapse of the upper airway during 
sleep which leads to total (apnoea) or substantial (hypopnoea) decrease in inspiration which 
lasts for at least ten seconds (13). The number of these events per hour - the 
apnoea/hypopnea index (AHI) - is taken as a measure of the severity of the condition. 
Conventionally people are classified as mild OSA if they have between 5-15 events an hour, 
moderate if they have between 15-30, and severe if they have >30 (14), as measured by 
Polysomnography (PSG). However, even within the relative objectivity of these criteria, 
there are still variations among researchers in diagnostic thresholds for airflow reduction, 
oxygen de-saturation and cortical arousal (15).  
Patients who snore but have an AHI less than five tend to be classed as primary or habitual 
snorers (16). OSA is relatively rare compared to snoring, and is generally estimated to affect 
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2-4% of the population, though estimates suggest that at least 15% of snorers have an AHI 
>15 (17). This large excess of snorers to OSA patients suggests that the vast majority of 
snorers are simple or non-apnoeic snorers (also variously called primary, habitual and 
socially disruptive snorers). One of the main concomitants of snoring is daytime sleepiness, 
which has been used as a diagnostic proxy, in the absence of PSG, for distinguishing OSA 
from SS. The justifying hypothesis is that disordered breathing in OSA disturbs sleep. 
However, as Svensson and colleagues (18) note, linkage between OSA and daytime 
sleepiness is not clear-cut. Many people with apnoea do not report daytime sleepiness, 
while many non-apnoeic snorers do. Guilleminault and colleagues (19) attempted to address 
some of these inconsistencies by suggesting that there is a distinct, third clinical entity 
between SS and OSA, marked by non-apnoeic, non-hypopnoeic changes in respiratory effort 
and associated cortical arousal - respiratory effort-related arousals (RERAs) - which are 
associated with daytime sleepiness. This postulated clinical entity, Upper Airway Resistance 
Syndrome (UARS) is still disputed (17). The gold standard for objectively  measuring 
increased upper airway resistance is a combination of pharyngo-oesophageal manometry 
(20) and PSG, with UARS being defined as an AHI <5, an oxygen saturation of 92%, and 
presence of RERAs (21). In practice the manometric diagnostic gold standard is rarely 
applied and the distinctions between UARS and OSA, and between UARS and SS are in part 
inferential, from subjective reports of daytime sleepiness. This reliance of disease 
classification upon subjective measures runs the risk of reifying clinical entities upon 
spurious criteria. For instance, patients who attract the UARS label tend to have more 
medically unexplained, or functional somatic, symptoms. As such, self-reports of daytime 
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sleepiness or fatigue may have little or no association with sleep quality (see 22), casting 
doubt on the reliability of the ontology of UARS. 
Given the blurred and disputed boundaries between SS, UARS and OSA, it is worth reviewing 
what is done in practice to distinguish and define them. Several criteria have been 
proposed. 
Definitions and Distinctions of Snoring 
Distinctions by anatomical and neurological markers  
Several authors have studied the structure and ultra-structure of the palate, following the 
hypothesis that snoring is a marker of pathology or abnormality of upper aerodigestive tract 
anatomy. The most popular version of this theory is the obstructive theory of snoring, which 
hypothesises that hypertrophy of uvular and palatal structures causes narrowing and 
collapse of airways. Karakoc and colleagues attempted to distinguish 133 SS and 131 OSA 
patients on an anatomical basis, although found no difference between groups in nasal 
obstruction (16). However, grouping patients according to their AHI category revealed 
significant differences in Fujita classification. The Fujita classification is a method of 
describing the location of any airway obstruction as seen by visual and endoscopic 
examination during sleep (23). SS patients were much more likely to be classified as type 1 
(upper pharyngeal) and OSA as type 2 (hypopharyngeal) (80% and 61%, respectively). 
Differences in AHI based on Mallampati classification - which approximates to the tongue 
size relative to palate and pharynx (24) - were also significant: the greater the relative 
tongue size, the higher the AHI category. Finally a measure of collapsibility of the pharyngeal 
walls was also positively and significantly related to AHI. All of this would suggest that there 
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are at least quantitative differences between SS and OSA, although there was no normal 
control group for comparison. By contrast, in a battery of similar measures comparing 20 SS 
with 32 mild and 22 moderate OSA patients, Balsevičius and colleagues found only clinical 
assessment of tonsil size distinguished SS from the other two groups: SS had a higher 
Friedman's score of palatal tonsils (25). In a radiographic (CT scanning) comparison 34 SS 
patients had, predictably, less pharyngeal narrowing than did 33 OSA patients,  but no 
useful quantitative metric emerged (13). 
A cephalometric study compared posterior airway space (PAS), mandibular plane and 
hypoid distance (MPH), craniofacial angle (C3FI), and soft palate length in OSA, SS and 
normal controls. (26). Greater MPH (reflecting downward displacement by the tongue base), 
longer soft palate and narrower PAS distinguished OSA/SS from normal controls. As 
expected, the MPH and PAS values were higher in OSA than SS (26). 
The clinical, endoscopic and radiographic anatomical literature suggests that whilst there 
are some markers that may be more pronounced in some OSA than SS patients, no single 
marker offers reliable clinical distinction. However the anatomical theory of snoring 
causation is not the only one to have been investigated.  
Bassiouny and colleagues investigated an alternative, neurogenic hypothesis of OSA (27). 
This postulates neural degeneration of local nerves, whereby the vibratory effect of snoring 
causes nerve atrophy which in turn leads to muscle atrophy (as opposed to the proposed 
muscular hypertrophy of the obstructive theory). Despite the small sample, there was 
evidence of excess nerve fibre degeneration in 10 OSA patients compared with non-apnoeic 
snorers or controls. Interestingly however, another study by the same authors found 
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evidence for the obstructive theory. They note that this area of research is new and 
evolving, and that detailed histological and neurological studies are small (28). 
Whilst often framed as mutually exclusive, there is no obvious reason why these two 
theories could not be complementary. Initial, subtle differences in the pharyngeal structure 
and ultra-structure could lead to snoring, which could cause neural and muscle atrophy of 
some muscles and compensatory hypertrophy of others, leading to more problem 
breathing, and further alterations in anatomy and further neural changes. Some theorists 
have attempted to chart the progression of SS to OSA by investigating a progressive sensory 
nerve degeneration hypothesis. Hagander and colleagues’ comparison of vibration and cold 
sensation detection in 23 controls, 13 SS and 31 OSA participants found that controls were 
distinct from both snorers and OSA in their cold detection ability (higher) (29). The authors 
postulate that the vibratory impact of snoring may be a self-perpetuating cycle, causing 
progressive nerve lesions that impair the ability of the upper airway muscle to maintain 
upper airway patency. If nothing else, this gives us reason to take SS seriously, even in the 
absence of present pathology or impairment.  
Distinction of SS from UARS 
Other authors have attempted to establish a neurological distinction of SS from normal 
controls and from UARS. Gates and colleagues report one of the few studies of autonomic 
dysregulation in 11 normotensive non-apnoeic snorers without UARS or cortical arousal, 
and found evidence of increased sympathetic and decreased parasympathetic nervous 
activity in snorers compared to controls (30). As autonomic dysregulation and heart rate 
variability are both part of the hypothesised mechanism whereby snoring can lead to 
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cardiovascular events, this work indicates that non-apnoeic snorers, even in the absence of 
UARS, are on a continuum of disease vulnerability, ending in severe OSA. In another study 
the same authors found that baroreflex sensitivity was decreased in normotensive healthy 
non-UARS snorers (31). Again, baroreflex sensitivity, part of the regulatory system 
controlling blood pressure, has been implicated in the causal chain, leading from sleep 
disruption in OSA to hypertension.  
The argument that simple snorers, rather than being a distinct group, are part of disease 
pathogenesis on a snoring continuum, is corroborated by a survey of all-cause mortality in 
77,260 snorers which indicated that increasing levels of snoring were linked to mortality, 
particularly in non-obese, non-apnoeic snorers (OR = 1.16). This indicates that SS is in itself a 
risk factor for increased mortality (32). Non-palatal snoring was particularly linked to 
mortality, independent of either AHI or body mass index (BMI). The data do allow for 
objective measurement of the mechanistic links between snoring and mortality, however 
they propose two likely candidate mechanisms, both of which echo the research reported 
above. The first is the direct effect of vibrations on carotid artery atherosclerosis, leading to 
cardiovascular mortality; the second is a more indirect route, similar to that proposed by 
Gates and colleagues whereby hypoxia and/or respiratory effort has a long term 
physiological impact (31). These authors are also cautious of endorsing UARS as a distinct 
entity. This also fits with the findings of the two studies by Gate’s team which seem to show 
that the effects of snoring on physiological functioning, as measured by autonomic 
dysregulation, occur independently of UARS or cortical arousal. Contrastingly, Pepin and 
colleague’s review of UARS concludes that there is no extant convincing evidence of any link 
between UARS per se and cardiac morbidity (17).  
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The nature of the distinction between UARS, OSA and SS is the focus of a large study by 
Stoohs and colleagues (22). They performed a retrospective chart analysis of 2753 patients, 
157 with SS, 424 with UARS, 562 with OSA and no sleepiness and 1610 with OSA and 
daytime sleepiness. Problematically, no formal analysis of RERAs was performed on the 
entire cohort to distinguish SS from UARS; rather they were distinguished according to self-
reported daytime sleepiness. As mentioned above, this subjective means of classifying UARS 
may be confounded by the relationship between UARS and functional somatic symptoms. 
However, subsequent to this subjective classification, a post-hoc subset analysis was 
performed on 15 patients with SS and 15 with UARS. Within this subset UARS did exhibit 
more RERAs within non-REM sleep during 40 randomly selected epochs than SS. However, 
there were no differences in objective measures between SS and UARS cohorts. Yet the 
UARS subset reported more subjective impairment than both OSA groups in measures of joy 
for life, depressive mood, ability to concentrate, difficulty with daytime activities and quality 
of life in general. These measures of subjective impairment were independent of sleep-
related breathing difficulties and BMI. Crucially, as the authors note, UARS perceived the 
quality of their sleep as worse than any other groups, but these subjective assessments bore 
no relationship to objective PSG findings.  
So, in sum, the UARS group, whilst otherwise indistinguishable from the SS group, had the 
highest levels of distress and subjective perception of daytime dysfunction. As mentioned, 
several authors (see 17, for a review) have noted overlap between UARS and functional 
somatic syndromes, and this would inform one interpretation of the findings of Stoohs and 
colleagues’ study. It could be argued that rather than being a distinct sleep disorder entity, 
UARS, certainly as measured here largely based on self-report, represents a sub-group of 
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people with snoring and low AHI who also have high general psychosomatic distress. Several 
other features of Stoohs’ study support this interpretation. The UARS group had the lowest 
levels of objective illness markers, including hypertension, but higher rates of self-reported 
reflux and rhinitis, both suggestive of autonomic dysfunction. They also reported high levels 
of daytime sleepiness and daytime naps, and had the highest female to male ratio (3:1) of 
any of the groups. This combination of high self-reported distress, autonomic dysfunction, 
increased prevalence of daytime sleepiness and daytime napping, and the female to male 
ratio are all identical to findings in populations with functional somatic syndromes such as 
CFS and Fibromyalgia (33, 34).   
Given this, the use of self-reported sleepiness should probably be considered with extreme 
caution in UARS. To their credit the authors do perform the 30 patient subset analysis, but 
this is both post-hoc and not necessarily representative of the cohort. Until more objectively 
classified, larger UARS cohort studies emerge, it remains unclear whether UARS is a distinct 
sleep disorder or merely a marker for people with mild sleep disordered breathing - SS in 
essence – who may also have functional somatic symptoms. Autonomic dysregulation may 
be an underlying mechanism involved in both. This merits further investigation. 
Distinction by daytime impairment 
The fact that sleepiness may not, in and of itself, be the best criterion by which to classify 
sleep –related breathing disorders is confirmed by two large studies that show that 
sleepiness is related to habitual snoring, independent of AHI index (18, 35). These 
observations not only reinforce understanding that snoring is problematic but also further 
questions using daytime fatigue and sleepiness as a criteria for classifying sleep disorders.  
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Taken together these studies suggest that anatomically, neurologically, physiologically and 
functionally the distinctions between SS and OSA are quantitative rather than qualitative, 
and that SS may be problematic in and of itself not only because it can progress to OSA but 
because it is independently associated with mortality and daytime dysfunction. The latter is 
further reviewed below, but the continuum, rather than the distinction between SS and OSA 
can be seen in most studies of daytime functioning. However the blurred lines between SS 
and OSA have not stopped researchers attempting to identify other means to distinguish 
them, with the sound of the snore being the most often investigated. 
Distinction by sound 
In reviewing the literature on the acoustic assessment of snoring, both Pevernagie and 
colleagues (36) and Mesquita and colleagues (37) note that the holy grail of snoring 
research is to find a relatively cheap and reliable marker of OSA that is based on objective 
biomarkers without employing full PSG. The attempt to do this by the monitoring and 
analysis of snoring sound, with single or multiple microphones, has been intensively studied 
over the last two decades. The main conclusion of Pevernagie and colleagues’ review is that 
current snoring sound technology and methodologies of sound analysis are highly variable, 
and conclusions regarding the relationship between sound quality and sleep disturbed 
breathing category unreliable. However, they assert that the ongoing attempt to assess 
acoustic information for the degree, or type, of sleep disordered breathing is a relevant 




If we take AHI index as a reasonably accurate measure of where people lie on the snoring 
spectrum, there have been several attempts to capture this acoustically in terms of 
loudness, duration and/or pattern of snoring. A large study of 4860 home sleep studies 
investigated the acoustic characteristics of snoring as related to AHI and a number of 
common health complaints (35). Snoring was measured by placing a pair of microphones on 
the upper lip, one to measure snoring and the other to cancel ambient sound. This was a 
population mostly of overweight men who had been referred for home sleep studies where 
snoring was part of their presenting complaint. Average loudness of snoring, peak loudness 
and duration of snoring were all highly significantly related to AHI. Sustained loudness had a 
correlation of 0.62 with AHI, and both sustained loudness and AHI were significant 
independent predictors of sleepiness as measured by the ESS. Again this indicates, as noted 
above, that SS may be problematic in and of itself, if the snoring is loud enough. This is 
supported by a study of 850 French males, where loudness of partner reported snoring was 
related to daytime sleepiness (38). Furthermore, Azarbarzin and Moussavi (39) examined 42 
OSA patients and 15 non-apnoeic snorers measured with a microphone over the 
suprasternal notch of the trachea. What distinguished the non-apnoeic snorers from the 
OSA patients was their lack of snoring sound variability. This parameter exhibited a high 
degree of accuracy and specificity in distinguishing the groups.   
Intensity and frequency of snores are also common candidate parameters for distinguishing 
degrees of sleep disordered breathing. Investigation of 37 snorers with a range of AHI 
scores, demonstrated that an all-night recording with automated scoring of intensity and 
frequency could reliably distinguish AHI classifications (40). A large study of snoring volume 
intensity in 1634 snorers divided into non-OSA, mild, moderate and severe OSA found a 
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strong correlation between intensity and AHI (0.66) (41). However variability is still high 
within AHI classifications, precluding the use of intensity as the sole measure of OSA 
classification.  
A contrasting approach is to analyse the segmental pattern of snoring sound generation 
(37). A cheap and reliable method based on analysis of the variability within a snoring 
segment and the time interval between the snoring segments showed intra-segment 
variability to be higher in OSA patients, whose time interval between snoring episodes was 
shorter. The analysis is novel in that the parameters studied were much fewer than in most 
acoustic analyses yet still provides reliable results. The study was relatively small (34 
participants with a range of AHI) and needs further validation.   
The main gist of this evolving field of research is that in problematic snoring, loudness, 
frequency and irregularity may be reliable markers of severity. 
Distinguishing and evaluating types of snoring 
The above findings support the conclusion that there is a continuum of snoring from SS to 
severe OSA and that the putative intermediate entity - UARS - needs further validation. This 
continuum is not only one of abnormality of anatomical and neurological dysfunction, but 
also one of related autonomic dysfunction, disease vulnerability, daytime dysfunction and 
even mortality. There is a range of techniques for evaluating the snorer, and attempting to 
classify them: from objective monitoring such as PSG, through visual examination, auditory 
recording, partner or self-reported snoring and breathing, and subjective daytime 
dysfunction. However, apart from the rarely applied "gold standard" PSGs, none is a reliable 




One of the few studies of the effect of early life events on adult snoring surveyed 16,190 
randomly selected adults in Sweden, Norway, Iceland, Denmark and Estonia (42). The main 
significant predictors of habitual snoring, here defined as ≥3 times per week, were recurring 
respiratory infections as a young child, recurrent otitis as a child, being part of a large family 
and having a family dog in childhood. The questionnaire was retrospective, and causal 
pathways speculative, but the authors suggest that all the identified factors are associated 
with increased risk of upper airway infection/inflammation which may lead to hypertrophy 
of the tonsils and thus narrowing of the upper airway. However they had no data on 
tonsillectomy to further investigate this hypothesis. This latter factor was investigated in a 
study comparing a group of 460 adult volunteers, 227 with tonsillectomy and 233 without 
tonsillectomy (43). Having had a tonsillectomy significantly reduced the odds of being both a 
habitual and a severe snorer (odds ratio [OR] 1.81 and 2.61 for non-tonsillectomy vs. 
tonsillectomy for habitual vs. severe snorers, respectively). This was independent of age, 
BMI and gender. It is hypothesised that the absence of tonsils widens the upper airway 
making snoring less likely. They further suggest that the fibrosis of the pharyngeal wall 
associated with tonsillectomy may prevent both collapse and vibration of the pharynx. As 
such their findings suggest that tonsillectomy reduces risk factors associated with both 
anatomical and neurological theories of snoring described above. Another anatomical risk 
factor is pointed out by Hiraki and colleagues (44). In a population survey of 1459 Japanese 
adults, snoring was significantly more prevalent in individuals with nasal obstruction and 
nasal obstruction with allergic rhinitis. However as these features were self-reported rather 
than clinically assessed, the results must be interpreted with caution.   
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A large population based survey of 15,555 adults examined the risks associated with active 
and passive smoking (45). Present smoking, past smoking and passive smoking all 
contributed to risk of snoring, independently of obesity, sex or age. Indeed, having ever 
smoked was associated with a much higher risk for developing snoring with the attributable 
risk being 17.1%, vs. 4.3% for obesity. Passive smoking had an attributable risk of 2.2%. 
Whilst most studies point out the association between BMI and snoring, few have studied 
this longitudinally. One study investigated the development of snoring in a cohort of 8967 
adults who had reported not snoring in a 1981 health survey and who were surveyed again 
in 1994-95 (46). Being male was associated with an odds ratio of 3.5 for developing habitual 
snoring. Baseline BMI was associated with a 1.4 odds ratio per 3.4kg/m
2 
for developing 
snoring. Change in BMI over the 14 year period was an independent risk factor for snoring 
development (OR 1.55 per 2.3kg/m
2
), as was development of asthma (OR 2.8) and starting 
smoking (OR 2.2). BMI was the focus of a study of 1890 obese adults in an Italian population 
(47). Whilst 56% of this population were snorers, snoring was positively and significantly 
associated with weight cycling and weight gain since the age of 20, echoing the longitudinal 
findings of Knuiman and colleagues (46). Further, in the Italian cohort, physical activity had a 
small but significant protective effect on snoring, independent of obesity.  
However, the relationship between BMI and snoring, whilst strong, needs to be considered 
in the light of other factors. Svensson and colleagues (48) examined the relationship 
between BMI and snoring in a random selection of 6817 Swedish women. Whilst the 
prevalence of self-reported snoring increased with increasing BMI, the strength of the 
relationship was age dependent. Both being overweight (BMI 25-30kg/m
2
) and being obese 
(BMI >30kg/m
2
) were strongly associated with snoring in the younger (<55 years) group 
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whereas in the older group (55+) only obesity predicted being a habitual snorer. A clear 
dose-response relationship between smoking and snoring was present only in women of 
normal weight. Positive associations between alcohol dependence and snoring were present 
only in under-weight women. This change in the association of risk factors across BMI 
categories has also been found in mixed gender studies. Nagayoshi and colleagues looked 
cross-sectionally at the associations between BMI, age, smoking, gender and alcohol in 3138 
men and 5345 women aged 35–79 years. BMI quartile (highest versus lowest) was 
associated with a 3.4 odds ratio of reporting everyday snoring (7). As in Svensson and 
colleague’s survey, they found that the effect for smoking and drinking was stronger in the 
low BMI (<25) than in the high BMI (>25) group. Both of these large studies report ageing 
and snoring being linearly associated until the fifth decade, where the association peaks. It 
then declines from the late fifth decade onwards.  
Whilst many studies have looked at health behaviours, lifestyle and early family 
environment, few have considered wider socio-demographic variables. In a large population 
survey of 12,270 adults, living in a rural area compared to an urban dwelling significantly 
increased odds of snoring, attributing this to exposure to bio-mass smoke (12). 
Demographic differences, such as BMI, neck circumference, or cranio-facial differences, may 
be responsible for ethnic differences in snoring prevalence (8, 9).  
 
In one of the largest snoring studies to date - a population based survey of 12,643 
Hungarian adults - Torza and colleagues examined an extensive list of socio-demographic 
factors and their association with snoring (3). This study was notable both for the range of 
epidemiological and individual factors studied and for its categorisation of snoring severity - 
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non-snorers, habitual snorers and loud snorers. Loud snoring was associated with low social 
status, poor education, poor health behaviours (drinking and smoking) and the presence of 
1 or more co-morbidities including diabetes, depression, musculoskeletal disorders and 
chronic pain. Across most of these variables, there was a graded difference between non-
snorers, habitual snorers and heavy snorers. E.g.  the self-reported prevalence of three or 
more co-morbid conditions rose significantly across the groups (28% vs. 35% vs. 43%, in 
non-snorers vs. habitual vs. loud snorers, respectively). A similar gradient was observed for 
the effects of snoring on daytime sleepiness and accidents. These large population based 
studies are rare and in some ways complicate our understanding of what causes snoring. For 
instance, is the association between education and snoring mediated by health behaviours? 
Their analysis would imply that it is not: lower levels of education predict snoring 
independently of BMI, smoking, drinking and age. However, this leaves the mechanism of 
association unclear. What this study does confirm is the fact that the distinctions between 
simple snoring and problematic snoring are a matter of degree rather than kind, and that 
simple snoring is in itself problematic. 
 
The consistent findings of the association between snoring and other markers of ill health 
has led some authors to suggest that snoring is part of, or a marker of, a wider syndrome. A 
cross sectional survey of 1193 Chinese adults demonstrated that levels of pro-insulin, a 
strong predictor of cardiovascular risk, was also associated with snoring (OR=1.2) (49). 
Another study demonstrated that snoring is associated with hypertension independent of 
obesity in just under 10,000 Korean adults (50). Additionally, a clear dose-response 
relationship was found between markers of metabolic syndrome - such as 
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hypertriglyceridemia, low hdl-cholesterol and high fasting glucose - and the presence of 
snoring. Both studies were cross sectional, and therefore whether metabolic markers may 
be a cause or consequence of snoring is unclear, but both point to snoring as a marker of a 
more general illness vulnerability (discussed further below), and again that the degree of 
snoring associated pathology is related to the degree, rather than the type, of snoring. 
 
Finally, the most consistent risk factor for snoring is being male. In one of the few meta-
analyses in the snoring field, Chan and colleagues (10) analysed 63 studies including 104,337 
males and 110,474 females. The combined M:F odds ratio was 1.89. In a useful discussion, 
they point out the usual reasons given for the relationship between gender and snoring:  the 
differences in upper airway anatomy and in the degree and kind of obesity between men 
and women. However, they also highlight that there may be some sociological mediation at 
work.  Women tend to report that snoring is more stigmatising than men, and there may be 
a tendency to over-report (male) partners’ snoring and under report their own. Given the 
robustness of the observed gender disparity these less researched aspects deserve further 
study.  
Daytime Dysfunction and Associated Difficulties 
The clinical significance of snoring in the absence of OSA, other respiratory disturbances 
during sleep, or other sleep complaints, is contentious. In this section we review research 
both supporting and refuting the existence of relationships between snoring and a number 
of health outcomes including cardiovascular disorder, metabolic syndrome, difficulties 
associated with daytime sleepiness, and its psychosocial impact on the bed-partner. Despite 
the wealth of both cross-sectional and longitudinal data on these associations, intricacies 
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and inconsistencies in the study designs hinder our ability to make an accurate judgement 
for or against the claim that snoring in the absence of OSA contributes to adverse health 
outcomes, although given the evidence presented above, its position on a continuum of 
OSA poses snoring itself as a risk factor for disease onset and progression.  
Cardiovascular and Cerebrovascular disease: A number of studies have investigated the 
associations between snoring and cardiovascular difficulties including hypertension, 
myocardial infarction and atherosclerosis, and conclusions are mixed. Most studies 
investigating the association between snoring and cardiovascular disease risk have focused 
on middle-aged men, most likely due to the increased prevalence of both difficulties 
compared to women, although studies of older adults appear in the literature. Studies 
investigating these associations typically consider snoring on a continuum based on 
frequency of occurrence (e.g. never snored, snoring sometimes a month, sometimes a 
week, or everyday) or intensity (e.g. mild, or moderate vs. heavy, as indicated by either 
acoustic analysis or percentage of sleep time spent snoring). Cross-sectional studies have 
demonstrated an association between snoring frequency and cardiovascular risk factors, 
including hypertension, hyperglycemia, hypercholesterolemia, hypertriglyceridemia, BMI 
and visceral obesity (49). Likewise, a study of women with type 2 diabetes demonstrated 
that snoring frequency was associated with similar biomarkers of cardiovascular disorders 
(17). Snoring frequency has also been associated with increased carotid artery intima-media 
thickness and the presence of plaque (together an indicator of subclinical atherosclerosis) 
(51). Similarly, heavy snoring, as compared to mild or moderate snoring, has been 
associated with risk for carotid atherosclerosis, independent of other risk factors including 
OSA severity (52). However, other studies have failed to find an association between carotid 
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artery intima-media thickness and snoring frequency (53), or atherosclerotic manifestations 
and snoring habits (54).  
Other studies have considered the confounding influence of age on the association between 
snoring and cardiovascular abnormalities. Male snorers <40 years of age in a Korean 
population survey showed a more pronounced  prevalence of hypertension than did snorers 
aged 40-60 years; whereas in female snorers, both age groups showed comparable 
increased prevalence of hypertension compared with non-snorers (55). In a larger, 
Hungarian population survey quiet snoring in women, regardless of age, was also associated 
with hypertension (56). Likewise, both young and old adult loud snorers with breathing 
pauses (as opposed to quiet snorers) were more likely than non-snorers to experience 
hypertension or myocardial infarction. Interestingly, prevalence of stroke showed a dose-
response relationship between snoring categories in younger adults only, whereas in older 
adults, stroke was equally common in non-snorers, quiet snorers and loud snorers with 
breathing pauses. This study is important as it suggests that informal, self-determined 
distinctions of different types of snoring may facilitate the identification of individuals at risk 
for severe cardiovascular disease, but also highlights that less severe snoring (quiet snoring 
without breathing pauses) has adverse cardiovascular concomitants. 
Longitudinal studies have also provided mixed evidence for the role of snoring as an 
independent predictor of cardiovascular difficulties. For example, a recent US government 
funded, longitudinal study of post-menopausal women demonstrated a 40% increased risk 
of stroke and all cause cardiovascular disease in frequent snorers (compared to occasional- 
or non-snorers) over the course of a decade, after controlling for other cardiovascular risk 
factors such as obesity, hypertension and diabetes (57). Another US study examined the 
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predictive value of snoring as a risk factor for mortality in the 8 years following myocardial 
infarction, and demonstrated that both occasional (including some occasions per year or 
month) and regular heavy snorers (daily) were twice as likely to die within 28 days following 
infarction than non-snorers after correcting for age, gender, obesity, history of diabetes and 
hypertension, physical activity, smoking, and education (58). This study demonstrates that 
even occasional snoring influences short-term mortality post myocardial infarction. In a 
study of hypertension, Kim and colleagues demonstrated that snoring in the absence of 
hypertension at baseline was associated with a 1.5 fold increased risk for hypertension at 2 
year follow-up (59). Others have focused on the role of daytime sleepiness in the prediction 
of adverse cardiovascular outcome. For example, Leineweber and colleagues demonstrated 
that snoring coupled with feelings of tiredness predicted increased progression of 
atherosclerosis over 3 years (60). A cross-sectional study demonstrated that the 
combination of snoring with EDS was a risk factor for hypertension, but not either 
symptoms in isolation (61). A recent longitudinal study of adults >70 years of age elegantly 
teased apart the effect of snoring and EDS on cardiovascular disease (including myocardial 
infarction, angina pectoris, or congestive heart failure) (62). Over a 9 year period, individuals 
exhibiting snoring with sleepiness at baseline were 40% more likely to have experienced a 
cardiovascular event at follow-up compared to those with only one of these symptoms. 
Similarly, another longitudinal study found that whilst snoring EDS was associated with 
increased mortality rate over a 10-year follow-up period in middle aged men, increased risk 
for mortality was not present in individuals exhibiting snoring without EDS (63). However, 
increased risk for mortality diminished in adults after 60 years of age, suggesting that 
snoring and EDS linked mortality decreases over the lifespan, perhaps as other factors pose 
23 
 
greater risk to mortality as one ages. In the context of OSA, some have suggested that 
moderate symptoms in older adults serve as a survival advantage (64). Thus, it is possible 
that the combination of snoring and daytime sleepiness, rather than snoring alone, predicts 
likelihood of cardiovascular complications. However, age effects are inconsistent. 
It is possible to posit several likely mechanisms through which snoring may influence 
cardiovascular difficulties. One study investigated chemoreceptor response during voluntary 
apnoea and demonstrated increased mean arterial blood pressure in snorers compared to 
non-snorers (65). Increased arterial blood pressure may be triggered by an increase in 
sympathetic activity following hypoxia, leading to an exaggerated cardiac response. It has 
been suggested that the efficiency of the baroreflex may be disrupted by continuously 
heightened sympathetic output in snorers (66). Although it is possible that intermittent 
hypoxia, repetitive desaturations and resultant increased sympathetic activity may 
contribute to cardiovascular complications, it has been suggested that snoring vibrations 
themselves have the potential to damage carotid arterial walls and contribute to plaque 
rupture as observed in atherosclerosis (67). A further possibility is that the association 
between snoring and cardiovascular events is mediated by obesity. Nagayoshi and 
colleagues demonstrated an increased risk of cardiovascular events including  myocardial 
infarction, angina pectoris, sudden cardiac death and stroke in female snorers, but that 
these associations were attenuated after adjusting for BMI (68). 
However, it should be noted that the majority of studies reviewed above did not explicitly 
exclude apnoea symptoms (such as breathing pauses) from their snoring groups. It is likely 
that at least some of the individuals categorised as habitual snorers within these studies 
may have also had apnoea (of which snoring is a primary symptom). Indeed, Joo and 
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colleagues, investigating snoring frequency highlighted that nearly half of their ‘snoring’ 
sample also exhibited OSA (69). Kamil and colleague’s cross-sectional study differentiated 
habitual snorers from clinically diagnosed OSA cases yet demonstrated increased risk for 
hypertension and ischemic heart disease in snorers, and albeit to a greater degree, in 
individuals with OSA (8). Contrastingly, one of the only longitudinal studies to differentiate 
habitual snorers from individuals with diagnosed OSA found that habitual snorers exhibited 
comparable risk of cardiovascular events as non-snorers, and that only individuals with OSA 
were at risk of cardiovascular events over a 7 year follow-up period (70). Likewise, a study 
which objectively measured snoring and its association with mortality, cardiovascular 
disease and stroke over the course of 17 years showed no effects of snoring after controlling 
for OSA (71). Thus, based on the current data, it is not possible to determine whether 
snoring in the absence of other apnoea-related symptoms (such as upper airway resistance) 
increases risk for cardiovascular disease. However, because snoring is considered a 
precursor to the development of apnoea, early identification and treatment could prevent 
disease progression. Further, self-reported snoring frequency could be used as a screening 
tool to aid in the detection and prevention of premature cardiovascular disease.  
Metabolic syndrome: Contrary to investigations of cardiovascular disease, recent studies 
of risk for metabolic syndrome in snorers have largely been cross-sectional. Leineweber and 
colleagues demonstrated a five-fold increased risk of snorers compared to non-snorers to 
experience metabolic syndrome defined using a combination of fasting serum glucose level, 
arterial blood pressure, fasting serum triglycerides, cholesterol, and obesity in a sample of 
healthy middle-aged women after controlling for age, menopause, smoking, activity level 
and education (72). Interestingly, this effect was independent of poor sleep quality, 
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suggesting that the mechanism of action is purely related to the respiratory difficulty, 
possibly through increasing micro-arousals and sleep fragmentation and disrupting the 
restorative value of sleep rather than its psychological effects on sleep. In a sample of 
middle-aged non-obese males habitual snorers compared to non-snorers had a 2-fold 
increased risk of elevated haemoglobin – an independent indicator of long-term glycaemic 
control, and thus, a potential risk factor for metabolic syndrome and cardiovascular disease 
(69). Shin and colleagues demonstrated that, whilst habitual snorers’ and non-snorers’ 
levels of fasting blood glucose and insulin were comparable, habitual snoring was associated 
with elevated glucose and insulin levels 2 hours following ingestion of glucose even after 
controlling for diabetes and hypertension in non-obese individuals (73). This study suggests 
that snoring may contribute to insulin resistance and impaired glucose homeostasis. Indeed 
this has been shown to be the case for OSA (74). Further, snoring has been linked to 
microalbuminuria – a persistent increase in urinary albumin – an early indicator of diabetes 
nephropathy (75). Interestingly, one study showed increased prevalence of diabetes in 
habitual snorers compared to non-snorers in women but not in men, after controlling for 
BMI and waist circumference (76). Note that increased risk of diabetes in snoring women 
has been noted previously (77). Although these studies were cross-sectional, it is possible to 
postulate that snoring may precede the development of metabolic syndrome. It has been 
suggested that the sleep-disordered breathing as in snoring may influence sympathetic 
nervous system hyperactivity (78), which may consequently impair glucose homeostasis and 
induce insulin resistance by increasing glycogenolysis and gluconeogenesis (79, 80). 
Additionally, hypoxia may promote the release of proinflammatory cytokines, including 
tumour necrosis factor-a and interleukin-6, which may result in impaired glucose tolerance 
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and insulin resistance (81, 82). One study demonstrated that regular snoring was associated 
with inflammatory markers, adipokines, and risk for metabolic syndrome, but that these 
effects were either attenuated or abolished after controlling for BMI or waist circumference 
(83). However, an alternative explanation is that risk for metabolic derangement is 
influenced by the severity of EDS accompanying snoring. Indeed, one study demonstrated 
that EDS in the absence of snoring was associated with increased risk for diabetes of a 
similar magnitude as EDS in the presence of snoring (61). Thus, from this study it is not 
possible to determine whether snoring, per se, exhibited effects on diabetes risk over and 
above effects due to associated EDS. A further mechanism is also likely. For example it has 
been suggested that diabetes may act as a risk factor for the development of OSA (75), 
possibly mediated by obesity and resultant obstruction to the upper airways. However, all of 
these studies suffer from the problem that apnoea was not ruled out. Prospective studies 
are required in order to determine causal relationships between snoring and metabolic 
abnormalities. 
Morning headache: Morning headache is a frequent accompanying symptom of OSA, but 
whether it occurs in snorers in the absence of sleep apnoea is a contentious claim. Ekici and 
colleagues demonstrated an increased prevalence of morning headaches as a function of 
snoring intensity, from ~30% in non-snorers to ~43% in extremely loud snorers  (12). 
Similarly, another study demonstrated a prevalence of around 23% of morning headache in 
habitual snorers (84). However, 69% of these snorers also had OSA, so it is difficult to 
determine the effect of snoring directly on morning headache. A prospective diary-based 
study indicated a prevalence of around 60% of snorers and their bed-partners to experience 
at least one morning headache over the course of 90 days (85). The latter study suggests 
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that the influence of snoring on morning headache may be mediated by sleep 
fragmentation, given its occurrence in bed-partners. 
Fragmented Sleep and Daytime Sleepiness: As outlined above, snoring is a risk factor 
for daytime sleepiness, even in the absence of apnoea (86). One study showed associations 
between snoring intensity, awakenings from sleep, daytime sleepiness and psychological 
distress (12). Snoring intensity also predicted likelihood of falling asleep at the wheel and 
traffic accidents, suggesting that sleepiness-related outcomes may lead to impairments in 
daytime performance, increasing the risk of detrimental consequences on the road. 
Although some studies use the criteria of habitual snoring and EDS to determine OSA, one 
study which examined habitual snorers who did not experience breathing pauses 
demonstrated that this group were 5 times more likely to exhibit daytime sleepiness (a 
score on the ESS ≥11) than non-snorers (8). In support another study demonstrated that the 
association between snoring and daytime sleepiness was independent of respiratory 
disturbance (87). 
Psychosocial Difficulties: Whilst it may be a matter of debate whether snoring in its own 
right has adverse health consequences, it is incontrovertible that for bed-partners, snoring is 
a serious annoyance that can impair sleep quality. In most cases, snorers are unaware of 
their snoring, and it is their bedpartner who urges them to seek help due to the disruption 
to their own sleep and their relationship. Indeed one study showed that female partners of 
male snorers had objectively poorer sleep quality and increased sleep fragmentation on a 
night with their partner compared to a night sleeping alone (88). Further, around one half of 
bed-partners reported that snoring contributed to their own constant sleep disturbances on 
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almost a nightly basis, around 40% had to sleep in another bedroom weekly, and a third 
reported that snoring contributed to disharmony in the relationship at least from time to 
time in one study (89). In addition to annoyance and disturbed sleep, snoring has also been 
shown to contribute to unilateral high-frequency hearing loss in bed-partners (90). Although 
little research has focused on simple snoring, research from the OSA literature has shown 
that sleeping with a partner with apnoea contributes to poor sleep and poor quality of life in 
the bedpartner (91). Another study examining changes in bedpartner depression, anxiety 
and sleepiness following radiofrequency tissue ablation in their snoring/OSA bedpartner, 
revealed reductions in depression in bedpartners of snorers (92). 
Conclusions: 
Despite the prevalence of snoring, we still know relatively little about its role as a predictor 
of serious health related outcomes independent of apnoea related phenomena. Likewise, 
the evidence surrounding the presence of daytime sleepiness in snoring is mixed, and it 
remains unclear whether non-apnoeic snoring contributes to daytime sleepiness in its own 
right. Part of this uncertainty is due to the variation across studies in their diagnosis of 
snoring in the absence of apnoeic symptoms, and the few studies that have clearly 
distinguished symptomology. Regardless of this, it is clear that snoring exists at one end of a 
continuum, with OSA at the polar end. This highlights the potential severity of an otherwise 
thought “annoying” problem – a problem which should be taken seriously in its own right. 
Treating snoring early in the natural history may prevent the development of more serious 
breathing related difficulties, consequently reducing risk for further complications such as 




1. Snoring is common worldwide, with prevalence rates ranging from 2% to 85% depending 
on diagnosis, age, gender and population. 
2. Snoring exists on a continuum from simple snoring, through UARS, to degrees of OSA. 
3. It is possible to distinguish snoring from UARS and OSA on several criteria, including 
anatomical and neurological markers, presence of daytime dysfunction, or acoustic analysis. 
However, research studies often rely on self-reported or partner-reported snoring 
symptoms. 
4. Risk factors for snoring include those associated with increased risk of upper airway 
infection/inflammation, nasal obstruction, BMI, smoking, alcohol dependence, rural 
dwelling and being male. 
5. It is unclear whether snoring independently poses risk for the development of poor health 
outcomes in the absence of OSA, although its presence on a continuum with the likely 




Research Agenda:  
1. Studies focussing on snoring, be they examining prevalence, risk factors or concomitant 
complaints, should differentiate simple snoring from apnoea related symptoms rather than 
blurring the distinctions between these groups. 
2. Longitudinal studies charting the time-course of development from snoring through to 
OSA are needed to provide support for the notion that snoring poses risk for OSA 
progression. 
3. If evidence supports the notion that snoring proceeds to OSA, investigation of the 
mechanisms underlying disease progression is warranted. 
4. Clearly phenotyped studies examining whether snoring does predict daytime sleepiness 
and consequent health complaints are necessary in order to determine whether such 
difficulties are a result of non-apnoeic snoring.  
5. Studies identifying the mechanisms underlying the association between snoring and 









AHI Apnoea-Hypopnea Index 
BMI Body Mass Index 
CFI Craniofacial Angle 
CFS Chronic Fatigue Syndrome 
EDS Excessive Daytime Sleepiness 
MPH Mandibular Plane and hyoid distance 
OSA Obstructive Sleep Apnoea 
PAS Posterior Airway Space 
PSG Polysomnography 
REM Rapid Eye Movement 
RERAs Respiratory Event Related Arousals 
SS Simple Snoring 
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